Comparative Study of Strategies for Management of Duchenne Myopathy (DM)
Status:
Unknown status
Trial end date:
2021-11-01
Target enrollment:
Participant gender:
Summary
1. Comparing different lines of treatment of Duchenne Myopathy (DM) and assessment of new
lines of treatment (mesenchymal stem cell, phosphodiesterase inhibitors) in reducing the
impact of disability in the patients with Duchenne Myopathy and slowing the progression
of cardiomyopathy
2. Upsetting and implementation of the best treatment plan for those children with Duchenne
myopathy which is suitable for the available resources in Assiut University Children
Hospital